John W. Poyhonen's Insider Trades & SAST Disclosures
John W. Poyhonen's most recent trade in Heron Therapeutics Inc was a trade of 4,564 Common Stock done . Disclosure was reported to the exchange on April 13, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John W. Poyhonen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 4,564 | 48,660 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 4,564 | 27,936 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.88 per share. | 13 Apr 2023 | 2,012 | 46,648 (0%) | 0% | 2.9 | 5,795 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 1,250 | 7,500 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 1,250 | 44,096 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 66,385 | 66,385 | - | - | Performance Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,564 | 32,500 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,564 | 44,858 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.17 per share. | 13 Jan 2023 | 2,012 | 42,846 (0%) | 0% | 3.2 | 6,378 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 1,250 | 40,294 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 1,250 | 8,750 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 4,564 | 41,056 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 4,564 | 37,064 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.76 per share. | 13 Oct 2022 | 2,012 | 39,044 (0%) | 0% | 3.8 | 7,565 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 1,250 | 10,000 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 1,250 | 36,492 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 165,961 | 165,961 | - | - | Employee Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2022 | 4,564 | 37,254 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2022 | 4,564 | 41,628 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.01 per share. | 13 Jul 2022 | 2,012 | 35,242 (0%) | 0% | 3.0 | 6,056 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2022 | 1,250 | 32,690 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2022 | 1,250 | 11,250 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2022 | 4,564 | 33,452 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2022 | 4,564 | 46,192 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.07 per share. | 13 Apr 2022 | 2,012 | 31,440 (0%) | 0% | 6.1 | 12,213 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2022 | 1,250 | 12,500 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2022 | 1,250 | 28,888 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 4,564 | 50,756 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 4,564 | 29,650 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.30 per share. | 13 Jan 2022 | 2,012 | 27,638 (0%) | 0% | 8.3 | 16,700 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 1,250 | 25,086 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 1,250 | 13,750 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Other type of transaction at price $ 9.36 per share. | 29 Oct 2021 | 817 | 23,836 (0%) | 0% | 9.4 | 7,646 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 92,200 | 92,200 | - | - | Employee Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 55,320 | 55,320 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2021 | 1,250 | 15,000 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2021 | 1,250 | 23,452 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.55 per share. | 13 Oct 2021 | 433 | 23,019 (0%) | 0% | 10.5 | 4,568 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 1,250 | 16,250 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 1,250 | 22,635 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Other type of transaction at price $ 13.90 per share. | 13 Jul 2021 | 971 | 21,385 (0%) | 0% | 13.9 | 13,494 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.48 per share. | 13 Jul 2021 | 433 | 22,202 (0%) | 0% | 13.5 | 5,837 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 1,250 | 17,500 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 1,250 | 20,847 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.66 per share. | 13 Apr 2021 | 433 | 20,414 (0%) | 0% | 16.7 | 7,214 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2021 | 1,250 | 20,030 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2021 | 1,250 | 18,750 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.16 per share. | 13 Jan 2021 | 433 | 19,597 (0%) | 0% | 18.2 | 7,863 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Other type of transaction at price $ 11.65 per share. | 30 Oct 2020 | 637 | 18,780 (0%) | 0% | 11.7 | 7,423 | Common Stock |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 170,000 | 170,000 | - | - | Employee Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | John W. Poyhonen | President & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 20,000 | 20,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges